Spots Global Cancer Trial Database for The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.

Official Title: An Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants With Advanced Malignancies Previously Enrolled in Studies of Pemigatinib

Study ID: NCT04949191

Conditions

Advanced Malignancies

Interventions

Pemigatinib

Retifanlimab

Pembrolizumab

Study Description

Brief Summary: Safety and tolerability of pemigatinib.in monotherapy or combination in patients that have participated in a previous parent study to treat advanced malignancies.

Detailed Description: A Phase 2 Open-Label, Multicenter, Rollover Study to evaluate the long term safety and tolerability of Pemigatinib and to provide Continued Treatment for Participants With Advanced Malignancies Previously Enrolled in Studies of Pemigatinib